iPSC-Derived Cell Therapies Summit
Evvnt Promotion / evvnt
Archivo
07.12.2021 - 09.12.2021 Virtual
Time: 9:00 am - 5:00 pm
Temas de la conferencia
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies
The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Innovate The Next Generation of Safe, Scalable and Cost-Effective iPSC-Derived Therapies
The explosion of excitement and investment in the iPSC field has ushered in a new era of cell therapy, with these cells establishing it’s place as the optimal starting material for cell therapies targeting cancer, autoimmune, cardiac disease and much more.
Organizador profesional (PCO)
Hanson Wade
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/853667-3?pid=4832
Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
Brochure: https://go.evvnt.com/853667-3?pid=4832
Speakers: Helen Tayton-Martin, CBO, Adaptimmune, Jo Brewer, Head of Allogenic Research, Adaptimmune, Andres Bratt-Leal, Co-Founder, Aspen Neuroscience and more
Información e inscripción:
https://go.evvnt.com/853667-1?pid=4832
Mr. Customer Services
Investigación clínica, Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
USD 1899.00 - USD 3597.00
USD 1899.00 - USD 3597.00
Los participantes esperaban
1000
1000
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
